These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 24239863)
1. A novel indole compound, AWT-489, inhibits prostaglandin D2-induced CD55 expression by acting on DP prostanoid receptors as an antagonist in LS174T human colon cancer cells. Oyama S; Fujino H; Yamazaki R; Okura I; Regan JW; Awata A; Arai T; Murayama T Arch Biochem Biophys; 2014 Jan; 541():21-9. PubMed ID: 24239863 [TBL] [Abstract][Full Text] [Related]
2. The human prostanoid DP receptor stimulates mucin secretion in LS174T cells. Wright DH; Ford-Hutchinson AW; Chadee K; Metters KM Br J Pharmacol; 2000 Dec; 131(8):1537-45. PubMed ID: 11139429 [TBL] [Abstract][Full Text] [Related]
3. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells. Hirano Y; Shichijo M; Deguchi M; Nagira M; Suzuki N; Nishitani Y; Hattori M; Arimura A Eur J Pharmacol; 2007 Mar; 560(1):81-8. PubMed ID: 17307163 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Monneret G; Gravel S; Diamond M; Rokach J; Powell WS Blood; 2001 Sep; 98(6):1942-8. PubMed ID: 11535533 [TBL] [Abstract][Full Text] [Related]
6. Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils. Cossette C; Walsh SE; Kim S; Lee GJ; Lawson JA; Bellone S; Rokach J; Powell WS J Pharmacol Exp Ther; 2007 Jan; 320(1):173-9. PubMed ID: 17041009 [TBL] [Abstract][Full Text] [Related]
7. Interaction of BW A868C, a prostanoid DP-receptor antagonist, with two receptor subtypes in the rabbit isolated saphenous vein. Lydford SJ; McKechnie KC; Leff P Prostaglandins; 1996 Aug; 52(2):125-39. PubMed ID: 8880898 [TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis in non-small cell lung carcinoma A549 cells by PGD₂ metabolite, 15d-PGJ₂. Wang JJ; Mak OT Cell Biol Int; 2011 Nov; 35(11):1089-96. PubMed ID: 21999315 [TBL] [Abstract][Full Text] [Related]
9. Indomethacin decreases EP2 prostanoid receptor expression in colon cancer cells. Fujino H; Chen XB; Regan JW; Murayama T Biochem Biophys Res Commun; 2007 Aug; 359(3):568-73. PubMed ID: 17555711 [TBL] [Abstract][Full Text] [Related]
10. Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor? Rangachari PK; Betti PA; Prior ET; Roberts LJ J Pharmacol Exp Ther; 1995 Nov; 275(2):611-7. PubMed ID: 7473146 [TBL] [Abstract][Full Text] [Related]
11. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors. Gallant MA; Samadfam R; Hackett JA; Antoniou J; Parent JL; de Brum-Fernandes AJ J Bone Miner Res; 2005 Apr; 20(4):672-81. PubMed ID: 15765187 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin D2 regulates human colonic ion transport via the DP1 receptor. Medani M; Collins D; Mohan HM; Walsh E; Winter DC; Baird AW Life Sci; 2015 Feb; 122():87-91. PubMed ID: 25534438 [TBL] [Abstract][Full Text] [Related]
13. Identification of an indole series of prostaglandin D2 receptor antagonists. Sturino CF; Lachance N; Boyd M; Berthelette C; Labelle M; Li L; Roy B; Scheigetz J; Tsou N; Brideau C; Cauchon E; Carriere MC; Denis D; Greig G; Kargman S; Lamontagne S; Mathieu MC; Sawyer N; Slipetz D; O'Neill G; Wang Z; Zamboni R; Metters KM; Young RN Bioorg Med Chem Lett; 2006 Jun; 16(11):3043-8. PubMed ID: 16529930 [TBL] [Abstract][Full Text] [Related]
14. Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells. Chan CL; Jones RL; Lau HY Br J Pharmacol; 2000 Feb; 129(3):589-97. PubMed ID: 10711359 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils. Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101 [TBL] [Abstract][Full Text] [Related]
16. Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice. Minami T; Okuda-Ashitaka E; Mori H; Ito S; Hayaishi O J Pharmacol Exp Ther; 1996 Sep; 278(3):1146-52. PubMed ID: 8819497 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2. Schuligoi R; Sedej M; Waldhoer M; Vukoja A; Sturm EM; Lippe IT; Peskar BA; Heinemann A J Leukoc Biol; 2009 Jan; 85(1):136-45. PubMed ID: 18835884 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Meja KK; Barnes PJ; Giembycz MA Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541 [TBL] [Abstract][Full Text] [Related]
20. The opposing role of two prostaglandin D2 receptors, DP and CRTH2, in human eosinophil migration. Chiba T; Ueki S; Ito W; Kato H; Kamada R; Takeda M; Kayaba H; Furue M; Chihara J Ann Allergy Asthma Immunol; 2011 Jun; 106(6):511-7. PubMed ID: 21624751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]